Literature DB >> 29900991

Expression of Connexin 43 in Synovial Tissue of Patients With Rheumatoid Arthritis.

Tomohiro Matsuki1, Yuji Arai1, Shinji Tsuchida1, Ryu Terauchi1, Ryo Oda1, Hiroyoshi Fujiwara1, Osam Mazda2, Toshikazu Kubo1.   

Abstract

OBJECTIVES: This study aims to identify the distribution and expression level of connexin 43 (Cx43) in synovial tissue in patients with rheumatoid arthritis (RA). PATIENTS AND METHODS: The expression of Cx43 in synovial tissue from eight patients with RA (2 males, 6 females; mean age 59.5±2.7 years; range 52 to 71 years), five patients with osteoarthritis (2 males, 3 females; mean age 68.4±2.7 years; range 61 to 81 years), and one normal female subject (mean age 61 year) was analyzed by quantitative reverse transcriptase polymerase chain reaction and immunohistochemistry of tissue sections. Induction of Cx43 following stimulation of human RA synovial fibroblasts with tumor necrosis factor-alpha (TNF-a) cultures was examined by quantitative reverse transcriptase polymerase chain reaction. The effect of small interfering ribonucleic acid targeting Cx43 (siCx43) on the expression of TNF-a and interleukin-6 was examined using quantitative reverse transcriptase polymerase chain reaction and enzyme-linked immunosorbent assays.
RESULTS: Connexin 43 was highly expressed in RA synovial tissue, which also expressed TNF-a, but was expressed lower in osteoarthritis and normal synovial tissue. Expression of Cx43 was markedly up-regulated in RA synovial fibroblasts after stimulation with TNF-a. The over-expression of pro- inflammatory cytokines was suppressed by transfection of siCx43.
CONCLUSION: This study shows that Cx43 is expressed in RA synovial tissue and that its expression is induced by stimulation with TNF-a. The expression of the pro-inflammatory cytokines was inhibited by transfection of siCx43. Cx43 may be a novel marker of inflammation in RA synovial tissue.

Entities:  

Keywords:  Connexin 43; gap junction; pro-inflammatory cytokine; rheumatoid arthritis; synovial tissue

Year:  2015        PMID: 29900991      PMCID: PMC5827867          DOI: 10.5606/ArchRheumatol.2016.5597

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


  23 in total

1.  Gap junctions in human synovial cells and tissue.

Authors:  O V Kolomytkin; A A Marino; K K Sadasivan; W D Meek; R E Wolf; V Hall; K J McCarthy; J A Albright
Journal:  J Cell Physiol       Date:  2000-07       Impact factor: 6.384

Review 2.  Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Authors:  N Woolacott; Y Bravo Vergel; N Hawkins; A Kainth; Z Khadjesari; K Misso; K Light; C Asseburg; S Palmer; K Claxton; I Bruce; M Sculpher; R Riemsma
Journal:  Health Technol Assess       Date:  2006-09       Impact factor: 4.014

3.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

Review 4.  Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors.

Authors:  Nunzio Bottini; Gary S Firestein
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

5.  Reciprocal regulation between proinflammatory cytokine-induced inducible NO synthase (iNOS) and connexin43 in bladder smooth muscle cells.

Authors:  Kai Li; Jian Yao; Liye Shi; Norifumi Sawada; Yuan Chi; Qiaojing Yan; Hiroyuki Matsue; Masanori Kitamura; Masayuki Takeda
Journal:  J Biol Chem       Date:  2011-09-29       Impact factor: 5.157

6.  Acute downregulation of connexin43 at wound sites leads to a reduced inflammatory response, enhanced keratinocyte proliferation and wound fibroblast migration.

Authors:  Ryoichi Mori; Kieran T Power; Chiuhui Mary Wang; Paul Martin; David L Becker
Journal:  J Cell Sci       Date:  2006-12-15       Impact factor: 5.285

7.  Cytokine effects on gap junction communication and connexin expression in human bladder smooth muscle cells and suburothelial myofibroblasts.

Authors:  Marco Heinrich; Andreas Oberbach; Nadine Schlichting; Jens-Uwe Stolzenburg; Jochen Neuhaus
Journal:  PLoS One       Date:  2011-06-02       Impact factor: 3.240

Review 8.  Advances in rheumatology: new targeted therapeutics.

Authors:  Paul P Tak; Joachim R Kalden
Journal:  Arthritis Res Ther       Date:  2011-05-25       Impact factor: 5.156

9.  Gap junctional communication in human osteoclasts in vitro and in vivo.

Authors:  A F Schilling; S Filke; T Lange; M Gebauer; S Brink; A Baranowsky; J Zustin; M Amling
Journal:  J Cell Mol Med       Date:  2008-02-08       Impact factor: 5.310

10.  Connexin43 enhances the expression of osteoarthritis-associated genes in synovial fibroblasts in culture.

Authors:  Aditi Gupta; Corinne Niger; Atum M Buo; Eric R Eidelman; Richard J Chen; Joseph P Stains
Journal:  BMC Musculoskelet Disord       Date:  2014-12-11       Impact factor: 2.362

View more
  3 in total

1.  Treadmill Running in Established Phase Arthritis Inhibits Joint Destruction in Rat Rheumatoid Arthritis Models.

Authors:  Yuta Fujii; Hiroaki Inoue; Yuji Arai; Seiji Shimomura; Shuji Nakagawa; Tsunao Kishida; Shinji Tsuchida; Yoichiro Kamada; Kenta Kaihara; Toshiharu Shirai; Ryu Terauchi; Shogo Toyama; Kazuya Ikoma; Osam Mazda; Yasuo Mikami
Journal:  Int J Mol Sci       Date:  2019-10-15       Impact factor: 5.923

Review 2.  Ultra-Low Dose Cytokines in Rheumatoid Arthritis, Three Birds with One Stone as the Rationale of the 2LARTH® Micro-Immunotherapy Treatment.

Authors:  Camille Jacques; Ilaria Floris; Béatrice Lejeune
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

3.  Treadmill Running Ameliorates Destruction of Articular Cartilage and Subchondral Bone, Not Only Synovitis, in a Rheumatoid Arthritis Rat Model.

Authors:  Seiji Shimomura; Hiroaki Inoue; Yuji Arai; Shuji Nakagawa; Yuta Fujii; Tsunao Kishida; Shohei Ichimaru; Shinji Tsuchida; Toshiharu Shirai; Kazuya Ikoma; Osam Mazda; Toshikazu Kubo
Journal:  Int J Mol Sci       Date:  2018-06-03       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.